ArticleJACC. Advances2023
Wearable Biosensors in Congenital Heart Disease: Needs to Advance the Field.
Article in JACC. Advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- The Role of Wearable Devices in the Management of Congenital Heart Disease.Journal of clinical medicine · 2026Review
- A systematic exploration of digital biomarkers for the detection of depressive episodes in bipolar disorder.Npj mental health research · 2026Article
- Diagnostic performance of wearable acoustic-electrocardiographic indices for screening secundum atrial septal defect in children.Frontiers in pediatrics · 2026Article
- Clinical perspectives on wearable devices for pediatric cyanotic congenital heart disease: an expert survey to inform the early development of a multiparametric wearable biosensor.Frontiers in medicine · 2026Article
- The Validation and Accuracy of Wearable Heart Rate Trackers in Children With Heart Disease: Prospective Cohort Study.JMIR formative research · 2025Article
- Role of artificial intelligence in congenital heart disease.World journal of clinical pediatrics · 2025Review
- Cardiological rehabilitation, prehabilitation, and cardiovascular prevention in adults with congenital heart defects: tasks and services of the German Pension Insurance-part 1: preventive cardiology and prehabilitation.Cardiovascular diagnosis and therapy · 2025Review
- Digital Health Technologies in Pediatric Infectious Disease and the Perspective of Patients and Healthcare Professionals: A Review.Health science reports · 2025Article
- Management of Pediatric Congenital Heart Disease.Journal of clinical medicine · 2024Article
- Advances in Wearable Biosensors for Healthcare: Current Trends, Applications, and Future Perspectives.Biosensors · 2024Review
- A Comprehensive Review on Advancements in Wearable Technologies: Revolutionizing Cardiovascular Medicine.Cureus · 2024Review
- Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling.Circulation · 2024Article
- Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives.Journal of the American Heart Association · 2024Review
- Evaluation and Management of Sudden Death Risk in Repaired Tetralogy of Fallot.Journal of personalized medicine · 2023Review
- Utility of smart watches for identifying arrhythmias in children.Communications medicine · 2023Article
- Risk Stratification for Sudden Cardiac Death in Repaired Tetralogy of Fallot.CJC pediatric and congenital heart disease · 2023Review
- E-Health: A Game Changer in Fetal and Neonatal Cardiology?Journal of clinical medicine · 2023Review
- Exercise, prescription and training in ACHD.International journal of cardiology. Congenital heart disease · 2023Review
- Advancing Wearable Technology for Monitoring Heart Activity in Paediatric Populations.CJC pediatric and congenital heart disease · 2023Article
- Textile-based Wearable to Monitor Heart Activity in Paediatric Population: A Pilot Study.CJC pediatric and congenital heart disease · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD) in the real-world setting, over longer durations, and across varying levels of activity. However, there are significant technical limitations to the use of wearable biosensors in CHD. Here, we review current applications of wearable biosensors in CHD; how clinical and research uses of wearable biosensors must consider various CHD physiologies; the technical challenges in developing wearable biosensors for CHD; and special considerations for digital biomarkers in CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.